Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Vomiting 3Nausea 3Breast Neoplasms 3Neoplasms 2

Interventions

Dexamethasone 22Ondansetron 20Aprepitant 20Palonosetron 17Granisetron 11Calcium Dobesilate 8Therapeutics 7Olanzapine 6dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 5casopitant 4Acupressure 4netupitant 3dolasetron 3Yoga 3Vincristine 3Radiotherapy 3Dronabinol 3Analgesia 3ginger extract 2fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Prochlorperazine 2Metoclopramide 2Mesna 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Nausea × netupitant × Clear all
NCT03040726 2023-10-17

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2/3 Completed
53 enrolled 15 charts

Nausea, Neoplasms, Vomiting

NCT04669132 2022-02-23

OLNEPA

Instituto Brasileiro de Controle do Cancer

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Nausea

NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡